chr3-64094813-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_198859.4(PRICKLE2):c.*4238C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.158 in 152,662 control chromosomes in the GnomAD database, including 2,439 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2433 hom., cov: 33)
Exomes 𝑓: 0.20 ( 6 hom. )
Consequence
PRICKLE2
NM_198859.4 3_prime_UTR
NM_198859.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.90
Genes affected
PRICKLE2 (HGNC:20340): (prickle planar cell polarity protein 2) This gene encodes a homolog of Drosophila prickle. The exact function of this gene is not known, however, studies in mice suggest that it may be involved in seizure prevention. Mutations in this gene are associated with progressive myoclonic epilepsy type 5. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-64094813-G-A is Benign according to our data. Variant chr3-64094813-G-A is described in ClinVar as [Benign]. Clinvar id is 346422.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.218 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRICKLE2 | NM_198859.4 | c.*4238C>T | 3_prime_UTR_variant | 8/8 | ENST00000638394.2 | ||
PRICKLE2-AS1 | NR_045697.1 | n.199-281G>A | intron_variant, non_coding_transcript_variant | ||||
PRICKLE2 | NM_001370528.1 | c.*4238C>T | 3_prime_UTR_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRICKLE2 | ENST00000638394.2 | c.*4238C>T | 3_prime_UTR_variant | 8/8 | 1 | NM_198859.4 | |||
PRICKLE2-AS1 | ENST00000482609.1 | n.199-281G>A | intron_variant, non_coding_transcript_variant | 1 | |||||
PRICKLE2 | ENST00000295902.11 | c.*4238C>T | 3_prime_UTR_variant | 9/9 | 5 | P1 | |||
PRICKLE2 | ENST00000564377.6 | c.*4238C>T | 3_prime_UTR_variant | 8/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.158 AC: 23971AN: 152114Hom.: 2433 Cov.: 33
GnomAD3 genomes
AF:
AC:
23971
AN:
152114
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.198 AC: 85AN: 430Hom.: 6 Cov.: 0 AF XY: 0.190 AC XY: 49AN XY: 258
GnomAD4 exome
AF:
AC:
85
AN:
430
Hom.:
Cov.:
0
AF XY:
AC XY:
49
AN XY:
258
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.157 AC: 23968AN: 152232Hom.: 2433 Cov.: 33 AF XY: 0.152 AC XY: 11325AN XY: 74438
GnomAD4 genome
AF:
AC:
23968
AN:
152232
Hom.:
Cov.:
33
AF XY:
AC XY:
11325
AN XY:
74438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
259
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Progressive myoclonic epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at